Detalles de la búsqueda
1.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355448
2.
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
Gynecol Oncol
; 166(1): 36-43, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550709
3.
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Gynecol Oncol
; 161(3): 755-761, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33888336
4.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Int J Gynecol Cancer
; 31(6): 875-882, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931498
5.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462317
6.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
Br J Cancer
; 119(5): 565-571, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30057406
7.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Gynecol Oncol
; 144(2): 256-259, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27993479
8.
Multiorgan failure caused by pembrolizumab and axitinib in a woman affected by metastatic clear cell renal cell carcinoma: A case report and literature review.
Medicine (Baltimore)
; 103(13): e37606, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552059
9.
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
J Clin Oncol
; 42(13): 1488-1498, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315944
10.
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Eur J Cancer
; 203: 114039, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598922
11.
The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer.
J Clin Med
; 12(17)2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685607
12.
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Tumori
; 109(5): 490-495, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36609207
13.
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1247291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781174
14.
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study.
Cancers (Basel)
; 16(1)2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201470
15.
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1357793, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38318323
16.
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Cancers (Basel)
; 15(4)2023 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831376
17.
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
Front Oncol
; 12: 880008, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692798
18.
Combined use of biomarkers for detection of ovarian cancer in high-risk women.
Tumour Biol
; 31(3): 209-15, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20393825
19.
Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
Tumori
; 96(6): 918-25, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21388052
20.
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.
Cancer Res
; 80(3): 624-638, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723001